The Relationship of Inflammation with Energetic Metabolism and Mitochondrial Dysfunction in Autistic Spectrum Disorders

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

According to the totality of inflammatory markers, a cluster of patients with autism spectrum disorders (ASD) and high levels of inflammation (N = 35, 70%) was identified. Discriminant analysis showed that the catabolite of the kynurenine pathway, which makes the greatest contribution to the pathogenesis of RAS, is quinolic acid. Dysregulation of energy metabolism has been revealed, including both the main pathways of catabolism (glycolysis, the Krebs cycle) and alternative pathways (beta-oxidation, ketogenesis, branched amino acid metabolism) with impaired mitochondrial function (meglutol) in patients with ASD. Correlations have been revealed for a number of energy exchange metabolites with indicators of inflammation. Inflammation in ASD is associated with dysregulation of energy metabolism and mitochondrial dysfunction. These data can serve as the basis for new treatment protocols, including anti-inflammatory therapy, metabolic correction, and restoration of mitochondrial function.

Full Text

Restricted Access

About the authors

V. O. Generalov

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

T. P. Klushnik

Medical Center “PlanetaMed”

Author for correspondence.
Email: klushnik2004@mail.ru
Korea, Republic of, Moscow

T. E. Obodzinskaya

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

G. V. Larionov

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

A. N. Aleksandrenkova

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

T. R. Sadykov

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

A. M. Yugai

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

Yu. V. Kazakova

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

L. A. Mamedov

Medical Center “PlanetaMed”

Email: klushnik2004@mail.ru
Russian Federation, Moscow

References

  1. Баландина О.В., Бондарь Е.А., Власов В.В., Григоренко Е.Л., Кузнецова Ю.Е., Кузюкова А.А., Лебедева Е.И., Мартынихин И.А., Менделевич В.Д., Мешкова Е.С., Намазова-Баранова Л.С., Новиков А.Ю., Осин Е.К., Портнова А.А., Рачин А.П., Романова Р.С., Сиволап Ю.П., Таланцева О.И., Устинова Н.В., Шарков А.А. // Клин. рекомендации “Расстройства аутистического спектра” 2024 ID: 594_3.
  2. Zeidan J., Fombone E., Scorah J., Ibrahim A., Durkin M.S., Saxena S., Yusuf A., Shih A., Elsabbagh M. Autism Research. 2022. V. 15. № 5. P. 778–790.
  3. Hughes H.K., Moreno R.J., Ashwood P. // Brain, Behavior, and Immunity. 2023. V.108 P. 245–254.
  4. Matta S.M., Hill-Yardin E.L., Crack P.J. // Brain, behavior, and immunity. 2019. V. 79. P. 75–90.
  5. Toscano C.V.A., Barros L., Lima A.B., Nunes T., Carvalho H.M., Gaspar J.M. // Neuroscience & Biobehavioral Reviews. 2021. V. 129. P. 63–74.
  6. Liao X., Yang J., Wang H., Li Y. // J. Psychiatr. Res. 2020. V. 130. P. 167–176.
  7. Liao X., Liu Y., Fu X., Li Y. // Molecular neurobiology. 2020. V. 57. P. 3424–3438.
  8. Shen Y., Zhong J.G., Lan W.T., Li Y.H., Gong J.H., Zhao B.X., Hou X.H. // Frontiers in Psychiatry. 2023. V. 14. P. 1086068.
  9. Than U.T.T., Nguyen L.T., Nguyen P.H., Nguyen X.H., Trinh D P., Hoang D.H., Nguyen P.A.T., Dang V.D. // Scientific Reports. 2023. V. 13. № 1. P. 22587.
  10. Клюшник Т.П., Андросова Л.В., Симашкова Н.В., Зозуля С.А., Отман И.Н., Коваль-Зайцев А.А. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2011. Т. 111. № 8. С. 4145.
  11. Hughes H.K., Moreno R.J., Ashwood P. // Brain, behavior, and immunity. 2023. V. 108. P. 245–254.
  12. Wang H., Ye J. // Reviews in Endocrine and Metabolic Disorders. 2015. V. 16. P. 47–54.
  13. Divella R., Gadaleta Caldarola G., Mazzocca A. // Journal of Clinical Medicine. 2022. V. 11. № 8. P. 2191.
  14. Liu X., Jiang N., Zhou W. // Molecules. 2023. V. 28. № 11. P. 4501.
  15. Elkins C., Li C. // Immunometabolism. 2022. V. 4. № 4. P. e00013.
  16. Morrison T., Watts E.R., Sadiku P., Walmsley S.R. // Immunological reviews. 2023. V. 314. № 1. P. 427–441.
  17. Будихина А.С., Пащенков М.В. // Иммунология. 2021. V. 42. № 1. P. 5–20.
  18. Симашкова Н.В., Клюшник Т.П., Якупова Л.П. // Психиатрия. 2018. Т. 78. № 2. С. 17–24.
  19. Доценко В.Л., Нешкова Е.А., Яровая Г.А. Вопр. мед. хим. 1994. Т. 40. № 3. С. 20–25.
  20. Нартикова В.Ф., Пасхина Т.С. // Вопр. мед. хим. 1979. Т. 25. № 4. С. 494–499.
  21. Скрипченко Н.В., Широкова А.С. // Нейрохирургия и неврология детского возраста. 2016. № 4. С. 16–25.
  22. Abou Chahla M.N., Khalil M.I., Comai S., Brundin L., Erhardt S., Guillemin G.J. // Brain Sciences. 2023. V. 13. № 3. P. 505.
  23. Шилов Ю.Е., Безруков М.В. // Вестник Российской академии медицинских наук. 2013. Т. 68. № 1. С. 35–41.
  24. Klyushnik T.P., Ivanov A.B., Petrov V.G. // Journal of Neurology and Psychiatry named after S.S. Korsakov. 2014. V. 114. № 2. P. 37.
  25. Зозуля С.А., Смирнова Л.К., Кузнецов Н.Е. // Психическое здоровье. 2017. Т. 15. №1. С. 11–18.
  26. Santana-Coelho D. // Brain, Behavior, & Immunity-Health. 2024. P. 10083
  27. Gevi F., Zolla L., Gabriele S., Persico A.M. // Molecular Autism. 2016. V. 7. P. 1–11.
  28. Saade M.C., Clark A.J., Parikh S.M. // Frontiers in Nutrition. 2022. V. 9. P. 1070435.
  29. Kominsky D.J., Campbell E.L., Colgan S.P. // The Journal of Immunology. 2010. V. 184. № 8. P. 4062–4068.
  30. Анашкина А.А., Ерлыкина Е.И. // Современные технологии в медицине. 2021. Т. 13. № 1. С. 78–92.
  31. Ye Z., Wang S., Zhang X., Li H., Xu Z., Zuo Y. // Frontiers in Endocrinology. 2020. V. 11. P. 617.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Russian Academy of Sciences